Successful etanercept use in an HIV-positive patient with rheumatoid arthritis

Journal of Clinical Rheumatology

Volumn 13, Issue 2, 2007, Pages 79-80

  Kaur, Primal P ^a   Chan, Virginia C ^a   Berney, Steven N ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Etanercept; HIV positive; Rheumatoid arthritis; TNF inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; ANTIRETROVIRUS AGENT; CORTICOSTEROID; EFAVIRENZ; ETANERCEPT; GOLD; HYDROXYCHLOROQUINE; INFLIXIMAB; LAMIVUDINE; PARACETAMOL; PREDNISONE; SALAZOSULFAPYRIDINE; STAVUDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; ASTHMA; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEPATITIS B; HEPATITIS C; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JOINT SWELLING; MALE; METERED DOSE INHALER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; IMMUNOGLOBULIN G; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 34247176700     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000260411.75599.39     Document Type: Article

References (9)

1. Reveille JD. Rheumatic manifestations of human immunodeficiency virus infection. In: Ruddy S, Harris ED Jr, Sledge CB, et al, eds. Kelley's Textbook of Rheumatology. 6th ed. Philadelphia, PA: WB Saunders; 2001:1507-1518.
2. Calabrese LH, Zein N, Vassilopoulos D. Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B and HIV infection. Ann Rheum Dis. 2004;63 (Suppl II):ii18-ii24.
3. Furst DE, Breedveld FC, Kalden JR, et al. Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002). Ann Rheum Dis. 2002;61 (Suppl II):ii2-ii7.
4. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in Rheumatoid Arthritis. N Engl J Med. 2001;344:907-916.
5. Rodriguez FM. Rheumatic manifestations of human immunodeficiency virus infection. Rheum Dis Clin North Am. 2003;29:145-161,viii.
6. Reyes-Teran G, Sierra-Madero JG, Martinez del Cerro V, et al. Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial. AIDS. 1996;10:1501-1507.
7. Aboulafia DM, Bundow D, Wilske K, et al. Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis. Mayo Clin Proc. 2000;75:1093-1098.
8. Gaylis N. Infliximab in the treatment of an HIV positive patient with Reiter's syndrome. J Rheumatol. 2003;30:407-411.
9. Bartke U, Venten I, Kreuter A, et al. Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab [letter]. Br J Dermatol. 2004;150:784-786.